Gilead to expand access to remdesivir, its promising coronavirus treatment
Gilead Sciences Inc. will expand access to its experimental anti-coronavirus drug SBECD-enabled remdesivir to accelerate its emergency use for multiple
Special issue “Cyclodextrin-Based Drug Delivery System”
Pharmaceutics, a peer-reviewed open access journal (Impact Factor: 4.77) on the science and technology of pharmaceutics and biopharmaceutics, published monthly
Gilead to expand access to remdesivir, its promising coronavirus treatment
Gilead Sciences Inc. will expand access to its experimental anti-coronavirus drug SBECD-enabled remdesivir to accelerate its emergency use for multiple
Chloroquine against Covid-19?
The antimalarial drug, chloroquine has been claimed effective in the treatment of patients infected by the novel emerged coronavirus, Covid-19
BIT’s 11th World Gene Convention-2020 postponed to 2021
Following the great success of past ten years, BIT’s 11th World Gene Convention-2020 (WGC-2020) planned to be held on June
Role of membrane cholesterol in virus infection: CDs and plant sterols against SARS-COV-2
A recent review of Italian researchers emphasized the role of membrane lipids in the infectivity mechanism of SARS-COV-2 (Covid-19) based
10th Global Nanotechnology Congress and Expo
10th Global Nanotechnology Congress and Expo will be organized in Frankfurt, Germany during November 23-24, 2020. The main theme of congress
Cyclo Therapeutics announces positive safety profile of its drug Trappsol Cyclo
Cyclo Therapeutics, Inc., a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC)
Old but Gold: Applicability of Sulfobutylether Beta Cyclodextrin in SARS-CoV (2002) detection
Coronavirus SARS-CoV caused an outbreak of severe acute respiratory syndrome (SARS) emerged in Guangdong Province, People’s Republic of China in
University Hospitals in US to conduct coronavirus clinical trials
University Hospitals in Cleveland, US is set to conduct two clinical trials of remdesivir to treat adult Covid-19 patients hospitalised
Ginkgo terpenoid against COVID-19
Due to the reported high ability of virulence of COVID_19 in recent months, several studies have been conducted to discover